BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8579749)

  • 1. Fas and FasL in the homeostatic regulation of immune responses.
    Lynch DH; Ramsdell F; Alderson MR
    Immunol Today; 1995 Dec; 16(12):569-74. PubMed ID: 8579749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
    Hirohata S
    Cell Immunol; 1997 Nov; 181(2):182-91. PubMed ID: 9398405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas/Fas ligand on the road: an apoptotic pathway common to AIDS, autoimmunity, lymphoproliferation and transplantation.
    Famularo G; Nucera E; Marcellini S; De Simone C
    Med Hypotheses; 1999 Jul; 53(1):50-62. PubMed ID: 10499826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxycycline induces Fas/Fas ligand-mediated apoptosis in Jurkat T lymphocytes.
    Liu J; Kuszynski CA; Baxter BT
    Biochem Biophys Res Commun; 1999 Jul; 260(2):562-7. PubMed ID: 10403806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
    An S; Yap D; Knox KA
    Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis.
    Li B; Bassiri H; Rossman MD; Kramer P; Eyuboglu AF; Torres M; Sada E; Imir T; Carding SR
    J Immunol; 1998 Aug; 161(3):1558-67. PubMed ID: 9686624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D; Savir A; Bhardwaj N; Elkon KB
    J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells.
    Desbarats J; Duke RC; Newell MK
    Nat Med; 1998 Dec; 4(12):1377-82. PubMed ID: 9846574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
    Rivoltini L; Radrizzani M; Accornero P; Squarcina P; Chiodoni C; Mazzocchi A; Castelli C; Tarsini P; Viggiano V; Belli F; Colombo MP; Parmiani G
    J Immunol; 1998 Aug; 161(3):1220-30. PubMed ID: 9686582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A death factor--the other side of the coin.
    Nagata S
    Behring Inst Mitt; 1996 Oct; (97):1-11. PubMed ID: 8950463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas and Fas ligand interactions in malignant disease.
    Owen-Schaub L; Chan H; Cusack JC; Roth J; Hill LL
    Int J Oncol; 2000 Jul; 17(1):5-12. PubMed ID: 10853011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway.
    Colamussi ML; Secchiero P; Gonelli A; Marchisio M; Zauli G; Capitani S
    J Leukoc Biol; 2001 Feb; 69(2):263-70. PubMed ID: 11272277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New kids in the block: the role of FasL and Fas in kidney damage.
    Ortiz A; Lorz C; Egido J
    J Nephrol; 1999; 12(3):150-8. PubMed ID: 10440512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Fas and FasL as mediators of anticancer chemotherapy.
    Poulaki V; Mitsiades CS; Mitsiades N
    Drug Resist Updat; 2001 Aug; 4(4):233-42. PubMed ID: 11991678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
    Ettinger R; Panka DJ; Wang JK; Stanger BZ; Ju ST; Marshak-Rothstein A
    J Immunol; 1995 May; 154(9):4302-8. PubMed ID: 7536768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas-FasL-mediated CD4+ T-cell apoptosis following stem cell transplantation.
    Singh RK; Varney ML; Buyukberber S; Ino K; Ageitos AG; Reed E; Tarantolo S; Talmadge JE
    Cancer Res; 1999 Jul; 59(13):3107-11. PubMed ID: 10397252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocytes express Fas ligand upon CD4 cross-linking and induce CD4+ T cells apoptosis: a possible mechanism of bystander cell death in HIV infection.
    Oyaizu N; Adachi Y; Hashimoto F; McCloskey TW; Hosaka N; Kayagaki N; Yagita H; Pahwa S
    J Immunol; 1997 Mar; 158(5):2456-63. PubMed ID: 9036997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
    Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.